47.4 F
Elizabeth City
Friday, March 5, 2021

New Standard in High-Risk Muscle-Invasive Bladder Cancer?

Must read

(MedPage Today) — Anti-PD-1 immunotherapy after radical surgery in high-risk muscle-invasive urothelial cancer improved disease-free survival (DFS), regardless of PD-L1 status, a randomized phase III trial showed.
In the intent-to-treat (ITT…
Read More

- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest article